Interactions between gut microbiota, food and the obese host

Trends in Food Science and Technology

Volumn 34, Issue 1, 2013, Pages 44-53

  Requena, Teresa ^a   Cotter, Paul ^b,c   Shahar, Danit R ^d   Kleiveland, Charlotte R ^e   Martínez Cuesta, M Carmen ^a   Peláez, Carmen ^a   Lea, Tor ^e  

^a INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL STUDIES; HUMAN MICROBIOTA; IMMUNE RESPONSE; INFLAMMATORY RESPONSE; INTESTINAL BARRIERS; MICROBIAL GROUPS; RECENT RESEARCHES; RESEARCH STUDIES;

BIOTECHNOLOGY; FOOD TECHNOLOGY;

NUTRITION;

ANIMALIA;

EID: 84887177543     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2013.08.007     Document Type: Review

References (90)

1. Amar J., Burcelin R., Ruidavets J.B., Cani P.D., Fauvel J., Alessi M.C., et al. Energy intake is associated with endotoxemia in apparently healthy men. American Journal of Clinical Nutrition 2008, 87:1219-1223.
2. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermúdez-Humarán L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 2011, 3:559-572.
3. An H.M., Park S.Y., Lee D.K., Kim J.R., Cha M.K., Lee S.W., et al. Antiobesity and lipid-lowering effects of Bifidobacterium spp. In high fat diet-induced obese rats. Lipids in Health and Disease 2011, 10:116.
4. Anderson J.L., Edney R.J., Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2012, 36:503-516.
5. Andersson U., Bränning C., Ahrné S., Molin G., Alenfall J., Onning G., et al. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Beneficial Microbes 2010, 1:189-196.
6. Angelakis E., Armougom F., Million M., Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiology 2012, 7:91-109.
7. Angelakis E., Bastelica D., Ben Amara A., El Filali A., Dutourb A., Mege J.L., et al. An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice. Microbial Pathogenesis 2012, 52:61-68.
8. Arora T., Anastasovska J., Gibson G., Tuohy K., Sharma R.K., Bell J., et al. Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet induced obese mice. British Journal of Nutrition 2012, 108:1382-1389.
9. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
10. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15718-15723.
11. Bäckhed F., Fraser C.M., Ringel Y., Sanders M.E., Sartor R.B., Sherman P.M., et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host and Microbe 2012, 12:611-622.
12. Baillie-Hamilton P.F. Chemical toxins: a hypothesis to explain the global obesity epidemic. Journal of Alternative and Complementary Medicine 2002, 8:185-192.
13. Basseri R.J., Basseri B., Pimentel M., Chong K., Youdim A., Low K., et al. Intestinal methane production in obese individuals is associated with a higher body mass index. Gastroenterology and Hepatology 2012, 8:22-28.
14. Bégin-Heck N., Bourassa M., Heick H.M. The effect of oxytetracycline on insulin resistance in obese mice. Biochemical Journal 1974, 142:465-475.
15. Brinkworth G.D., Noakes M., Clifton P.M., Bird A.R. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. British Journal of Nutrition 2009, 101:1493-1502.
16. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
17. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
18. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
19. Caricilli A.M., Picardi P.K., de Abreu L.L., Ueno M., Prada P.O., Ropelle E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLOS Biology 2011, 9:e1001212.
20. Cario E. Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunology 2008, 1(Suppl. 1):S62-S66.
21. Carvalho B.M., Guadagnini D., Tsukumo D.M., Schenka A.A., Latuf-Filho P., Vassallo J., et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012, 55:2823-2834.
22. Chen J.J., Wang R., Li X.F., Wang R.L. Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. British Journal of Nutrition 2012, 107:1429-1434.
23. Cho I., Yamanishi S., Cox L., Methé B.A., Zavadil J., Li K., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012, 488:621-626.
24. Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270.
25. Collado M.C., Isolauri E., Laitinen K., Salminen S. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. American Journal of Clinical Nutrition 2010, 92:1023-1230.
26. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002, 122:867-874.
27. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.P., Massart S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14691-14696.
28. Delzenne N.M., Neyrinck A.M., Bäckhed F., Cani P.D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews Endocrinology 2011, 7:639-646.
29. De Wit N., Derrien M., Bosch-Vermeulen H., Oosterink E., Keshtkar S., Duval C., et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. American Journal of Physiology Gastrointestinal and Liver Physiology 2012, 303:G589-G599.
30. Dewulf E.M., Cani P.D., Neyrinck A.M., Possemiers S., Van Holle A., Muccioli G.G., et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. Journal of Nutritional Biochemistry 2011, 22:712-722.
31. Drong A.W., Lindgren C.M., McCarthy M.I. The genetic and epigenetic basis of type 2 diabetes and obesity. Clinical Pharmacology & Therapeutics 2012, 92:707-715.
32. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., Lobley G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Applied and Environmental Microbiology 2007, 73:1073-1078.
33. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., et al. Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity 2008, 32:1720-1724.
34. Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S., Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. British Journal of Nutrition 2010, 104:919-929.
35. Flint H.J. The impact of nutrition on the human microbiome. Nutrition Reviews 2012, 70(Suppl. 1):S10-S13.
36. Gøbel R.J., Larsen N., Jakobsen M., Mølgaard C., Michaelsen K.F. Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. Journal of Pediatric Gastroenterology and Nutrition 2012, 55:673-678.
37. Greenblum S., Turnbaugh P.J., Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:594-599.
38. Grün F. Obesogens. Current Opinion in Endocrinology, Diabetes and Obesity 2010, 17:453-459.
39. Guo B., Harstall C., Louie T., Veldhuyzen van Zanten S., Dieleman L.A. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Alimentary Pharmacology and Therapeutics 2012, 35:865-875.
40. Hamad E.M., Sato M., Uzu K., Yoshida T., Higashi S., Kawakami H., et al. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. British Journal of Nutrition 2009, 101:716-724.
41. Haslam D.W., James W.P.T. Obesity. Lancet 2005, 366:1197-1209.
42. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
43. Huse S.M., Dethlefsen L., Huber J.A., Mark Welch D., Relman D.A., Sogin M.L. Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLOS Genetics 2008, 4:e1000255.
44. Isolauri E. Development of healthy gut microbiota early in life. Journal of Paediatrics and Child Health 2012, 48(Suppl. 3):1-6.
45. Ji Y.S., Kim H.N., Park H.J., Lee J.E., Yeo S.Y., Yang J.S., et al. Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28. Beneficial Microbes 2012, 3:13-22.
46. Jiménez E., Marín M.L., Martín R., Odriozola J.M., Olivares M., Xaus J., et al. Is meconium from healthy newborns actually sterile?. Research in Microbiology 2008, 159:187-193.
47. Jumpertz R., Le D.S., Turnbaugh P.J., Trinidad C., Bogardus C., Gordon J.I., et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. American Journal of Clinical Nutrition 2011, 94:58-65.
48. Kadooka Y., Sato M., Imaizumi K., Ogawa A., Ikuyama K., Akai Y., et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 2010, 64:636-643.
49. Kalliomäki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition 2008, 87:534-538.
50. Kang J.H., Yun S.I., Park H.O. Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. Journal of Microbiology 2010, 48:712-714.
51. Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R., et al. Succession of microbial consortia in the developing infant gut microbiome. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(Suppl. 1):4578-4585.
52. Koh-Banerjee P., Franz M., Sampson L., Liu S., Jacobs D.R., Spiegelman D., et al. Changes in whole-grain, bran, andcereal fiber consumption in relation to 8-y weight gain among men. American Journal of Clinical Nutrition 2004, 80:1237-1245.
53. Kondo S., Xiao J.Z., Satoh T., Odamaki T., Takahashi S., Sugahara H., et al. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience Biotechnology and Biochemistry 2010, 74:1656-1661.
54. Leber B., Tripolt N.J., Blattl D., Eder M., Wascher T.C., Pieber T.R., et al. The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. European Journal of Clinical Nutrition 2012, 66:1110-1115.
55. Ledikwe J.H., Ello-Martin J.A., Rolls B.J. Portion sizes and the obesity epidemic. Journal of Nutrition 2005, 135:905-909.
56. Ley R.E., Hamady M., Lozupone C., Turnbaugh P.J., Ramey R.R., Bircher J.S., et al. Evolution of mammals and their gut microbes. Science 2008, 320:1647-1651.
57. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
58. Martín R., Langa S., Reviriego C., Jiménez E., Marín M.L., Xaus J., et al. Human milk is a source of lactic acid bacteria for the infant gut. Journal of Pediatrics 2003, 143:754-758.
59. McCracken V.J., Lorenz R.G. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiology 2001, 3:1-11.
60. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P.D., Burcelin R.G., et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB Journal 2008, 22:2416-2426.
61. Million M., Maraninchi M., Henry M., Armougom F., Richet H., Carrieri P., et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International Journal of Obesity 2012, 36:817-825.
62. Murphy E.F., Cotter P.D., Hogan A., O'Sullivan O., Joyce A., Fouhy F., et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 2013, 62:220-226.
63. Naito E., Yoshida Y., Makino K., Kounoshi Y., Kunihiro S., Takahashi R., et al. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. Journal of Applied Microbiology 2011, 110:650-657.
64. Neyrinck A.M., Possemiers S., Druart C., Van de Wiele T., De Backer F., Cani P.D., et al. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLOS One 2011, 6:e20944.
65. Pal D., Dasgupta S., Kundu R., Maitra S., Das G., Mukhopadhyay S., et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature Medicine 2012, 18:1279-1285.
66. Parnell J.A., Reimer R.A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. American Journal of Clinical Nutrition 2009, 89:1751-1759.
67. Parnell J.A., Reimer R.A. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp rats. British Journal of Nutrition 2012, 107:601-613.
68. Poggi M., Bastelica D., Gual P., Iglesias M.A., Gremeaux T., Knauf C., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007, 50:1267-1276.
69. Prentice A.M., Jebb S.A. Fast foods, energy density and obesity: a possible mechanistic link. Obesity Reviews 2003, 4:187-194.
70. Richardson W.M., Sodhi C.P., Russo A., Siggers R.H., Afrazi A., Gribar S.C., et al. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 2010, 139:904-917.
71. Samuel B.S., Gordon J.I. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:10011-10016.
72. Samuel B.S., Shaito A., Motoike T., Rey F.E., Bäckhed F., Manchester J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:16767-16772.
73. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N.A., Donus C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010, 18:190-195.
74. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 2006, 116:3015-3025.
75. Snedeker S.M., Hay A.G. Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes?. Environmental Health Perspectives 2012, 120:332-339.
76. Takemura N., Okubo T., Sonoyama K. Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Experimental Biology and Medicine 2010, 235:849-856.
77. Thompson A.L. Developmental origins of obesity: early feeding environments, infant growth, and the intestinal microbiome. American Journal of Human Biology 2012, 24:350-360.
78. Tucker L.A., Thomas K.S. Increasing total fiber intake reduces risk of weight and fat gains in women. Journal of Nutrition 2009, 139:576-581.
79. Turnbaugh P.J., Bäckhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host and Microbe 2008, 3:213-223.
80. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
81. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
82. Vajro P., Mandato C., Licenziati M.R., Franzese A., Vitale D.F., Lenta S., et al. Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. Journal of Pediatric Gastroenterology and Nutrition 2011, 52:740-743.
83. Van de Wiele T., Vanhaecke L., Boeckaert C., Peru K., Headley J., Verstraete W., et al. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environmental Health Perspectives 2005, 113:6-10.
84. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
85. Vrieze A., Van Nood E., Holleman F., Salojärvi J., Kootte R.S., Bartelsman J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916.
86. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:3698-3703.
87. Wostmann B.S. The germ-free animal in nutritional studies. Annual Review of Nutrition 1981, 1:257-279.
88. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.Y., Keilbaugh S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
89. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Domínguez-Bello M.G., Contreras M., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
90. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2365-2370.